Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

822
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
822
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

239
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
239
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

194
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
194
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

20
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
20
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

569
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
569
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

390
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
390

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Stability and Robustness of a Generalized Pump-Leak Model for Epithelial Vesicles.

Bulletin of mathematical biology·2026
Same journal

Personalized Spatiotemporal Radiotherapy for GBM: A PDE-Constrained Optimization Study.

Bulletin of mathematical biology·2026
Same journal

Global Stability Analysis of a Mathematical Model for the "Shock-and-Kill" Strategy in HIV-1/SIV Brain Infection.

Bulletin of mathematical biology·2026
Same journal

Phylogenetic Network Models as Graphical Models.

Bulletin of mathematical biology·2026
Same journal

Mathematical Modeling Shows that Overall Infection Burden is Reduced More by Vaccines that Decrease Spread or Accelerate Recovery than those that Lower Severe Infections or Death.

Bulletin of mathematical biology·2026
Same journal

Effects of Seasonal Births and Predation on Disease Spread.

Bulletin of mathematical biology·2026

Related Experiment Video

Updated: Feb 17, 2026

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

3.1K

An Invitation to Pharmacostatics.

Gilles Gnacadja1

  • 1Amgen, South San Francisco, CA, USA. gilles.gnacadja@gmail.com.

Bulletin of Mathematical Biology
|December 8, 2017
PubMed
Summary

This study introduces pharmacostatics, focusing on equilibrium states in drug interactions. It proposes novel mathematical methods to analyze dose-response curves, improving biopharmaceutical research by addressing limitations in current practices.

Keywords:
Equilibrium calculationFixed-point algorithmNon-monotone dose-response curvePharmacostaticsPolynomial system solvingReceptor pharmacology

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.8K

Related Experiment Videos

Last Updated: Feb 17, 2026

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

3.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.8K

Area of Science:

  • Pharmacology
  • Biophysics
  • Mathematical Biology

Background:

  • Traditional pharmacology focuses on pharmacokinetics and pharmacodynamics.
  • Discovery-stage pharmacology requires understanding equilibrium states (pharmacostatics).
  • Current methods for pharmacostatics rely on approximations and may fail for complex networks.

Purpose of the Study:

  • To highlight mathematical challenges in pharmacostatics.
  • To propose algorithmic and theoretical solutions for analyzing drug-target interactions.
  • To improve the characterization of dose-response curves and network properties.

Main Methods:

  • Developing an algorithmic approach based on a fixed-point formulation of equilibrium equations.
  • Analyzing network topology to predict non-monotone dose-response curves.
  • Investigating reversible binding reaction networks.

Main Results:

  • A novel algorithmic method for pharmacostatics is proposed, offering advantages over current practices.
  • A framework is established to predict non-monotone dose-response curves from network topology.
  • The study addresses limitations in analyzing complex biological and therapeutic interactions.

Conclusions:

  • Mathematical approaches are crucial for advancing pharmacostatics.
  • The proposed methods can enhance biopharmaceutical research and drug discovery.
  • Further investigation into these mathematical problems is warranted for their inherent scientific value.